MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

MSD has started a phase 3 trial of ROR1-directed zilovertamab vedotin (zilo-V) as a treatment for previously untreated diffuse large B-cell lymphoma (DLBCL), cementing the antibody-drug conjugate's ...

China has conducted the first ignition test for the world's most powerful solid-propellant rocket engine. [Photo/Chinanews.com] China has conducted the first ignition test for the world's most ...

China's rocket scientists and engineers have been working on creating reusable rockets for several years and have recently made substantial progress. The latest advance was the successful re-ignition ...